P

Inventor

TRAXLER PETER

US28 patents
⚠️ This page may combine multiple inventors who share the name “TRAXLER PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NOVARTIS AG

15 patents
US6258812B1Jul 10, 2001

Phthalazines with angiogenesis inhibiting activity

NOVARTIS AG206 citations98
US5981533ANov 9, 1999

Pyrazole derivatives and processes for the preparation thereof

NOVARTIS AG104 citations98
US6140332AOct 31, 2000

Pyrrolopyrimidines and processes for the preparation thereof

NOVARTIS AG214 citations97
US6251911B1Jun 26, 2001

Pyrimidine derivatives and processes for the preparation thereof

NOVARTIS AG64 citations96
US6180636B1Jan 30, 2001

Substituted pyrrolopyrimidines and processes for their preparation

NOVARTIS AG78 citations96
US5686457ANov 11, 1997

Pyrrolopyrimidine derivatives having pharmacological activity

NOVARTIS AG92 citations96
US6710047B2Mar 23, 2004

Phthalazines with angiogenesis inhibiting activity

NOVARTIS AG25 citations92
US6514974B2Feb 4, 2003

Pyrido-, pyrimido-, pyridazo- and pyrazo- pyridazines having angiogenesis inhibiting activity

NOVARTIS AG15 citations92
US6140317AOct 31, 2000

Pyrrolopyrimidines and processes for their preparation

NOVARTIS AG37 citations92
US6096749AAug 1, 2000

Pyrrolopyrimidine derivatives having pharmacological activity

NOVARTIS AG42 citations92
US7244729B2Jul 17, 2007

4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives

NOVARTIS AG6 citations74
US7323469B2Jan 29, 2008

7H-pyrrolo[2,3-d]pyrimidine derivatives

NOVARTIS AG4 citations63
US7723339B2May 25, 2010

Combination comprising a signal transduction inhibitor and an epothilone derivative

NOVARTIS AG2 citations58
US7390805B2Jun 24, 2008

4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives

NOVARTIS AG0 citations52
US7879868B2Feb 1, 2011

Use of imatinib (glivec,sti-571) to inhibit breast cancer resistance protein (BCRP)-mediated resistance to therapeutic agents

NOVARTIS AG0 citations50

CIBA GEIGY CORP

13 patents